SUPERNUS PHARMS FDA Approval NDA 202810

NDA 202810

SUPERNUS PHARMS

FDA Drug Application

Application #202810

Documents

Label2012-10-22
Label2015-12-08
Review2012-11-29
Medication Guide2012-10-22
Summary Review2012-11-29
Letter2012-10-23
Letter2015-12-08
Pediatric Medical Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Statistical Review1900-01-01
Letter2018-12-20
Label2019-01-09

Application Sponsors

NDA 202810SUPERNUS PHARMS

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET, EXTENDED RELEASE;ORAL150MG1OXTELLAR XROXCARBAZEPINE
002TABLET, EXTENDED RELEASE;ORAL300MG1OXTELLAR XROXCARBAZEPINE
003TABLET, EXTENDED RELEASE;ORAL600MG1OXTELLAR XROXCARBAZEPINE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2012-10-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2013-08-23STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2015-09-11STANDARD
LABELING; LabelingSUPPL5AP2015-12-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2015-12-23STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2016-06-17STANDARD
EFFICACY; EfficacySUPPL10AP2018-12-13STANDARD

Submissions Property Types

ORIG1Null31
SUPPL2Null0
SUPPL4Null0
SUPPL5Null15
SUPPL6Null0
SUPPL7Null0
SUPPL10Null7

CDER Filings

SUPERNUS PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202810
            [companyName] => SUPERNUS PHARMS
            [docInserts] => ["Medication Guide","http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/202810s000mg.pdf"]
            [products] => [{"drugName":"OXTELLAR XR","activeIngredients":"OXCARBAZEPINE","strength":"150MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"No"},{"drugName":"OXTELLAR XR","activeIngredients":"OXCARBAZEPINE","strength":"300MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"No"},{"drugName":"OXTELLAR XR","activeIngredients":"OXCARBAZEPINE","strength":"600MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"12\/13\/2018","submission":"SUPPL-10","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/202810s010lbl.pdf\"}]","notes":""},{"actionDate":"12\/04\/2015","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/202810s005lbl.pdf\"}]","notes":""},{"actionDate":"10\/19\/2012","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/202810s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"10\/19\/2012","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 3 - New Dosage Form","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/202810s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2012\\\/202810Org1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2012\\\/202810_oxtellarxr_toc.cfm\"},{\"name\":\"Summary Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2012\\\/202810Orig1s000SumR.pdf\"}]","notes":">"}]
            [supplements] => [{"actionDate":"12\/13\/2018","submission":"SUPPL-10","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/202810s010lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/202810s010ltr.pdf\"}]","notes":">"},{"actionDate":"06\/17\/2016","submission":"SUPPL-7","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"12\/23\/2015","submission":"SUPPL-6","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"12\/04\/2015","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/202810s005lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/202810Orig1s005ltr.pdf\"}]","notes":">"},{"actionDate":"09\/11\/2015","submission":"SUPPL-4","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"08\/23\/2013","submission":"SUPPL-2","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"06\/14\/2013","submission":"SUPPL-1","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2018-12-13
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.